DE69534186D1 - Impfstoff gegen Streptokokkeninfektionen der Gruppe A - Google Patents

Impfstoff gegen Streptokokkeninfektionen der Gruppe A

Info

Publication number
DE69534186D1
DE69534186D1 DE69534186T DE69534186T DE69534186D1 DE 69534186 D1 DE69534186 D1 DE 69534186D1 DE 69534186 T DE69534186 T DE 69534186T DE 69534186 T DE69534186 T DE 69534186T DE 69534186 D1 DE69534186 D1 DE 69534186D1
Authority
DE
Germany
Prior art keywords
group
fragment
vaccine against
compositions
cysteine protease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69534186T
Other languages
English (en)
Other versions
DE69534186T2 (de
Inventor
A Musser
Vivek Kapur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Application granted granted Critical
Publication of DE69534186D1 publication Critical patent/DE69534186D1/de
Publication of DE69534186T2 publication Critical patent/DE69534186T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
DE69534186T 1994-09-14 1995-09-13 Impfstoff gegen Streptokokkeninfektionen der Gruppe A Expired - Fee Related DE69534186T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30654294A 1994-09-14 1994-09-14
US306542 1994-09-14
PCT/US1995/011723 WO1996008569A2 (en) 1994-09-14 1995-09-13 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof

Publications (2)

Publication Number Publication Date
DE69534186D1 true DE69534186D1 (de) 2005-06-09
DE69534186T2 DE69534186T2 (de) 2006-03-09

Family

ID=23185762

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69534186T Expired - Fee Related DE69534186T2 (de) 1994-09-14 1995-09-13 Impfstoff gegen Streptokokkeninfektionen der Gruppe A

Country Status (9)

Country Link
US (1) US6030835A (de)
EP (1) EP0781340B1 (de)
JP (2) JPH10505752A (de)
AT (1) ATE294868T1 (de)
AU (1) AU714435B2 (de)
CA (1) CA2199867A1 (de)
DE (1) DE69534186T2 (de)
ES (1) ES2242191T3 (de)
WO (1) WO1996008569A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601901D0 (sv) * 1996-05-20 1996-05-20 Lars Bjoerck Quinine antagonists for use as a pharmaceutical
US6242210B1 (en) 1997-05-20 2001-06-05 Actinova Limited Treatment of bacterial infections
US7087235B2 (en) * 1997-06-25 2006-08-08 The United States Of America As Represented By The Secretary Of The Army Fusion protein of streptococcal pyrogenic exotoxins
JP2002543434A (ja) 1999-04-29 2002-12-17 デイド マイクロスキャン インコーポレーテッド 迅速な抗菌物質感受性アッセイと微生物同定を組み合わせたシステム
CA2881568C (en) * 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
JP2006518191A (ja) * 2003-01-09 2006-08-10 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 細菌ワクチンベクターの免疫原性を強化するための組成物、方法、及びキット
ATE525478T1 (de) * 2003-12-05 2011-10-15 Univ Mcgill Serumbiomarker für morbus chagas
US9115382B2 (en) * 2004-06-03 2015-08-25 Leroy E. Mosher Kit for detection of hemolytic Streptococcus
US7316910B2 (en) * 2004-06-03 2008-01-08 Kinase Scientific, Llc Rapid test for hemolytic streptococcus
WO2012040434A2 (en) * 2010-09-23 2012-03-29 Eci Biotech, Inc. Ultrasensitive detection of beta hemolytic streptococcus
WO2013020090A2 (en) 2011-08-04 2013-02-07 The Regents Of The University Of California STREPTOCOCCAL GLcNAc-LACKING GLYCOPOLYPEPTIDES, CELL WALL CARBOHYDRATES, STREPTOCOCCUS VACCINES, AND METHODS FOR MAKING AND USING THEM
WO2015192216A1 (en) 2014-06-20 2015-12-23 University Of Saskatchewan Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
WO2021252810A1 (en) 2020-06-10 2021-12-16 Checkable Medical Incorporated In vitro diagnostic device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454121A (en) * 1982-07-27 1984-06-12 The University Of Tennessee Research Corporation Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
EP0362274B1 (de) * 1987-06-05 1994-03-23 Commonwealth Scientific And Industrial Research Organisation Behandlung und diagnose von klauenseuche unter verwendung der basischen protease von bacteroides nodosus
FR2685334B1 (fr) * 1991-12-23 1995-05-05 Bio Merieux Polypeptides contenant des sequences caracteristiques de pyrrolidone carboxylyl peptidases, polynucleotides contenant une sequence codant pour de tels polypeptides, et leur utilisation.
DE4240056A1 (de) * 1992-11-28 1994-06-01 Boehringer Mannheim Gmbh Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper

Also Published As

Publication number Publication date
AU714435B2 (en) 2000-01-06
EP0781340A1 (de) 1997-07-02
CA2199867A1 (en) 1996-03-21
JP3920271B2 (ja) 2007-05-30
EP0781340B1 (de) 2005-05-04
DE69534186T2 (de) 2006-03-09
AU3553895A (en) 1996-03-29
JP2004187688A (ja) 2004-07-08
JPH10505752A (ja) 1998-06-09
WO1996008569A3 (en) 1996-07-18
ES2242191T3 (es) 2005-11-01
WO1996008569A2 (en) 1996-03-21
US6030835A (en) 2000-02-29
ATE294868T1 (de) 2005-05-15

Similar Documents

Publication Publication Date Title
DE69534186D1 (de) Impfstoff gegen Streptokokkeninfektionen der Gruppe A
HUP0301656A2 (hu) Streptococcus antigének
DE60139963D1 (de) Fusionsproteine aus mycobakterium tuberculosis
BR0208944A (pt) quadros de leitura aberta de streptococus pneumoniae codificando os antìgenos de polipeptìdeos e seus usos
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
ATE252640T1 (de) Verbindungen zur immunotherapie und diagnose von tuberkulose
DE69635783D1 (de) Antigen omp26 aus haemophilus influenzae
UA27788C2 (uk) Композиція, що містить виділений фактор лелістада, вакцинна композиція для вакцинації тварин (варіанти), діагностичний набір для виявлення антитіла
ES8705522A1 (es) Un procedimiento para la preparacion de derivados purificados de una glicoproteina.
HUP0500459A2 (hu) Streptococcus suis vakcinák és diagnosztikai tesztek
HUP9901112A2 (hu) Szintetikus HIV-gének
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
HUP0105379A2 (hu) Lawsonia intracellularis elleni oltóanyag
ATE240351T1 (de) Rib-protein, ein oberflächenprotein welches immunität gegen viele streptococcus-stämme der gruppe b verleiht, reinigungsverfahren für das rib-protein, testsatz und pharmazeutische zusammenstellung (arznei)
WO2003070187A3 (en) Fusion proteins of mycobacterium tuberculosis
ATE355375T1 (de) Bakterioferritin aus helicobacter pylori
HUP0100130A2 (hu) Rekombináns Mycoplasma hyopneumoniae vakcina
DK1334196T3 (da) Genomisk fragment af Streptococcus suis og kliniske anvendelser deraf
ATE366583T1 (de) Identifizierung von spezifischen differenziell exprimierten antigenen aus mycobacterium und medizinische verwendung der mycobakteriumproteine rv0068 und rv3407
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
DE60234772D1 (de) Gruppe-b streptococcus antigene und entsprechende dna-fragmente
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee